Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,130.00
(
0.48%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
100.31
(
-0.34%
)
Bitcoin
74,236.01
(
0.40%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

iwfal

Send PM Follow Ignore
Followers 77
Posts 4790
Boards Moderated 0
Alias Born 09/06/2003

iwfal

Re: DewDiligence post# 40311

Friday, 01/05/2007 12:18:20 PM

Friday, January 05, 2007 12:18:20 PM

Post# of 257253
Its partner AtheroGenics Inc <AGIX> hopes to present results from a pivotal Phase III clinical trial to the American College of Cardiology (ACC) meeting in New Orleans in March and analysts noted the deadline for research submissions was Jan. 4.

Most (all?) conferences allow you to submit a placeholder if you think you will have news before the event. So I don't think the above logic holds. FWIW.

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now